Picrosides I and II Ameliorate Steatosis by Modulating Lipogenesis, Mitochondrial Biogenesis, and Autophagy in Hepatic Cells
Cell Biology International · 2026-06 · 50 (6)
DOI: 10.1002/cbin.70170 ↗At a glance
Journal article in Cell Biology International, published online on 2026-05-27. Written by Swati Katoch and 3 co-authors. Institution: Pharmacology and Toxicology Laboratory, Dietetics & Nutrition Technology Division, CSIR-Institute of Himalayan Bioresource Technology, Palampur, H.P.…. Major MEDLINE topics: Autophagy, Lipogenesis, Fatty Liver, Hepatocytes. 49 references. Funded by: CSIR, Department of Biotechnology, Government of India, Council for Scientific and Industrial Research, South Africa.
Abstract (original language)
Metabolic dysfunction‐associated steatotic liver disease (MASLD) is marked by excessive fat accumulation in the hepatocytes. In the present study, the protective efficacy of picroside I and II against steatosis was studied using combination of in silico and in vitro approaches. The in silico studies revealed moderate to high binding affinity of the picroside I and II with the various proteins involved in mitochondrial biogenesis and autophagy. Further, picrosides I and II treatment significantly reduced the lipid accumulation and triglyceride levels in the palmitate‐oleate (PO)‐treated Huh7 cells. Picrosides significantly downregulated various lipogenic markers ( SREBP1c , ChREBP, SCD1 , and FAS ) and upregulated AMPKα . The PO treatment elevated ROS production and lipid peroxidation (MDA) in the hepatic cells, which was significantly lowered by picrosides. PO treatment also led to mitochondrial dysfunction; however, picrosides significantly restored mitochondrial function by improving mitochondrial membrane potential (MMP), mitochondrial DNA levels and upregulating the mitochondrial biogenesis ( PGC1α , TFAM , NRF1 and NRF2 ). Further, picrosides lowered the levels of inflammatory cytokines (TNF‐α, IL6 and IL1β) and expressions of NFκB in the PO‐treated Huh7 cells. PO treatment impaired the autophagy by altering the expressions of autophagy markers ( SQSTM1 , BECN1 , MAPLC3A , ATG5 , and ATG7 ) in the PO‐treated Huh7 cells. Picroside treatment improved the autophagic flux by modulating the expressions of various autophagy biomarkers. In conclusion, the picroside I and II effectively prevented the steatohepatitis by lowering the lipogenesis, oxidative stress and inflammation, which improved the mitochondrial biogenesis and autophagic reflux in the hepatic cells.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Pharmacology and Toxicology Laboratory, Dietetics & Nutrition Technology Division, CSIR-Institute of Himalayan Bioresource Technology, Palampur, H.P., India.
- Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, India.
- Artificial Intelligence for Computational Biology (AICoB) Laboratory, Biotechnology Division, CSIR-Institute of Himalayan Bioresource Technology, Palampur, H.P., India.
ORCID profiles: Vikram Patial
Funding
- CSIR
- Department of Biotechnology, Government of India
- Council for Scientific and Industrial Research, South Africa
Cite
APA
Katoch, S., Jatin, Acharya, V., & Patial, V. (2026). Picrosides I and II Ameliorate Steatosis by Modulating Lipogenesis, Mitochondrial Biogenesis, and Autophagy in Hepatic Cells. Cell Biology International, 50(6). https://doi.org/10.1002/cbin.70170
Vancouver
Katoch S, Jatin, Acharya V, Patial V. Picrosides I and II Ameliorate Steatosis by Modulating Lipogenesis, Mitochondrial Biogenesis, and Autophagy in Hepatic Cells. Cell Biology International. 2026;50(6). doi:10.1002/cbin.70170
BibTeX
@article{Katoch2026,
author = {Katoch, Swati and Jatin and Acharya, Vishal and Patial, Vikram},
title = {Picrosides I and II Ameliorate Steatosis by Modulating Lipogenesis, Mitochondrial Biogenesis, and Autophagy in Hepatic Cells},
journal = {Cell Biology International},
year = {2026},
volume = {50},
number = {6},
doi = {10.1002/cbin.70170}
}
EUVIMED